Nir Sassi
Net worth: 80 274 $ as of 30/06/2026
Net worth: 80 274 $ as of 30/06/2026
Nir Sassi worked as Senior Manager at PricewaterhouseCoopers (Israel) from 2002 to 2010.
Served as Chief Financial Officer at Intec Pharma Ltd. from 2016 to 2021.
Served as Chief Financial Officer at Indaptus Therapeutics, Inc. from 2021 to 2023.
Completed undergraduate studies at Ben-Gurion University of the Negev.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 22/12/2025 | 26,758 ( 0.02% ) | 80 274 $ | 30/06/2026 |
| Companies | Position | End |
|---|---|---|
| INDAPTUS THERAPEUTICS, INC. | Director of Finance/CFO | 01/04/2026 |
PricewaterhouseCoopers (Israel)
PricewaterhouseCoopers (Israel) Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | 01/01/2010 |
Intec Pharma Ltd.
Intec Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products to treat neurodegenerative diseases | Director of Finance/CFO | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 4 |
|---|---|
PricewaterhouseCoopers (Israel)
PricewaterhouseCoopers (Israel) Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Ben-Gurion University of the Negev
Ben-Gurion University of the Negev Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Intec Pharma Ltd.
Intec Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products to treat neurodegenerative diseases | Health Technology |
Indaptus Therapeutics, Inc.
Indaptus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Select your edition
All financial news and data tailored to specific country editions